Natural killer cells against human corneal endothelium

Prior research has shown that immune responses can affect corneal graft outcomes. It was already known that lymphocytes can interact with endothelial cells. However, the specific role of nonsensitized lymphocytes in corneal endothelial injury remained unclear. No prior work had resolved how lymphocyte binding correlates with cell death in this context. This gap motivated further investigation into the mechanisms of lymphocyte-mediated damage. That uncertainty drove the need to identify the lymphocyte subpopulations involved. The study aimed to clarify whether natural killer cells contribute to corneal endothelium destruction. Understanding these interactions could inform strategies to prevent graft rejection.

The aim was to determine if nonsensitized peripheral blood lymphocytes can damage corneal endothelial cells in vitro. Researchers sought to identify the lymphocyte subpopulations responsible for this effect. They focused on whether these cells resemble natural killer cells in function and phenotype. The study aimed to measure binding rates and viability changes in endothelial cells. Researchers also wanted to assess if lymphocyte binding correlates with cytotoxicity. The goal was to clarify the immune mechanisms underlying corneal graft injury. They hypothesized that natural killer-like cells might play a role in endothelial cell death. This could help explain immune-mediated damage in corneal transplants.

Researchers incubated corneal endothelial cell monolayers with peripheral blood lymphocytes. They used vital and supravital staining to assess cell viability and binding. Direct immunofluorescence identified lymphocyte phenotypes. The study measured conjugate formation after six hours of incubation. Lymphocyte binding was quantified per thousand endothelial cells. Cytotoxicity assays compared treated cells to media-only controls. The lymphocyte population was analyzed for surface markers like Leu-11. Researchers evaluated the absence of surface immunoglobulin in binding cells.

Spontaneous lymphocyte-endothelial cell conjugates peaked at 86 per 1,000 cells after six hours. Cytotoxicity assays showed reduced endothelial viability compared to controls. The binding lymphocytes were large granular nonadherent cells. These cells lacked surface immunoglobulin expression. They stained positively for Leu-11 antigen, a natural killer cell marker. The data suggest these lymphocytes can recognize and kill endothelial cells. The observed effects occurred without prior sensitization. These findings imply a role for natural killer-like cells in endothelial injury.

The authors propose that nonsensitized lymphocytes can damage corneal endothelial cells in vitro. These cells exhibit functional and phenotypic traits of natural killer cells. Lymphocyte binding and cytotoxicity correlate with endothelial cell death. The study suggests natural killer-like cells may contribute to graft injury. The findings highlight the potential role of innate immunity in corneal rejection. Researchers emphasize the need to understand lymphocyte-endothelial interactions further. These results may inform strategies to prevent immune-mediated graft failure. The study does not claim these cells are essential but suggests they may be important.